Pharmaceuticals Ultrasector Profund Fund Fundamentals
| PHPIX Fund | USD 27.85 0.48 1.75% |
Pharmaceuticals Ultrasector Profund fundamentals help investors to digest information that contributes to Pharmaceuticals Ultrasector's financial success or failures. It also enables traders to predict the movement of Pharmaceuticals Mutual Fund. The fundamental analysis module provides a way to measure Pharmaceuticals Ultrasector's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmaceuticals Ultrasector mutual fund.
Pharmaceuticals |
Pharmaceuticals Ultrasector Profund Mutual Fund Price To Earning Analysis
Pharmaceuticals Ultrasector's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Pharmaceuticals Ultrasector Price To Earning | 6.90 X |
Most of Pharmaceuticals Ultrasector's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmaceuticals Ultrasector Profund is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Pharmaceuticals Ultrasector Price To Earning Component Assessment
Based on the latest financial disclosure, Pharmaceuticals Ultrasector Profund has a Price To Earning of 6.9 times. This is 70.69% lower than that of the ProFunds family and 68.54% lower than that of the Family category. The price to earning for all United States funds is 5.67% lower than that of the firm.
Pharmaceuticals Ultrasector Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmaceuticals Ultrasector's current stock value. Our valuation model uses many indicators to compare Pharmaceuticals Ultrasector value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmaceuticals Ultrasector competition to find correlations between indicators driving Pharmaceuticals Ultrasector's intrinsic value. More Info.Pharmaceuticals Ultrasector Profund is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about 0.40 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Pharmaceuticals Ultrasector Profund is roughly 2.49 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmaceuticals Ultrasector's earnings, one of the primary drivers of an investment's value.Pharmaceuticals Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmaceuticals Ultrasector's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Pharmaceuticals Ultrasector could also be used in its relative valuation, which is a method of valuing Pharmaceuticals Ultrasector by comparing valuation metrics of similar companies.Pharmaceuticals Ultrasector is currently under evaluation in price to earning among similar funds.
Fund Asset Allocation for Pharmaceuticals Ultrasector
The fund consists of 79.98% investments in stocks, with the rest of investments allocated between different money market instruments and various exotic instruments.Asset allocation divides Pharmaceuticals Ultrasector's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Pharmaceuticals Fundamentals
| Price To Earning | 6.90 X | ||||
| Price To Book | 2.77 X | ||||
| Price To Sales | 4.71 X | ||||
| Total Asset | 3.04 M | ||||
| Annual Yield | 0 % | ||||
| Year To Date Return | 14.26 % | ||||
| One Year Return | 37.63 % | ||||
| Three Year Return | (1.32) % | ||||
| Five Year Return | 6.50 % | ||||
| Ten Year Return | 14.01 % | ||||
| Net Asset | 3.27 M | ||||
| Cash Position Weight | 19.93 % | ||||
| Equity Positions Weight | 79.98 % |
About Pharmaceuticals Ultrasector Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmaceuticals Ultrasector Profund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmaceuticals Ultrasector using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmaceuticals Ultrasector Profund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the SP Total Market Index, which comprises the following sub-industry pharmaceuticals. The fund is non-diversified.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |